CME Group awarded Tobin Jack J 700 shares at $275.09 per share, leaving him with 26,109 shares before separate forfeiture transactions reduced his holding to 25,762. The transactions matter to investors because the award represented about 2.7% of his resulting holding and the forfeitures about 1.3% of his prior holding.
Key Highlights
- Transaction code A classified the 700-share award to Tobin Jack J.
- Four code F transactions covered 347 forfeited CME Group shares.
- The forfeiture prices ranged from $272.46 to $275.09 per share.
CME GROUP INC. (NASDAQ: CME) awarded Tobin Jack J, MD Chief Accounting Officer, 700 shares at $275.09 per share on 15 September 2026. His resulting holding was 26,109 shares.
Award and Four Subsequent Forfeitures
Tobin Jack J then forfeited 347 CME Group shares across four separate transactions between 15 September 2026 and 16 September 2026. Prices for the forfeited shares ranged from $272.46 to $275.09 per share. After those transactions, Tobin Jack J held 25,762 CME Group shares.
Holdings Measured Against Transaction Size
The 700-share award represented about 2.7% of Tobin Jack J’s resulting share holding. The 347 forfeited shares represented about 1.3% of his prior share holding.
FAQs
Q: How many CME Group shares did Tobin Jack J receive?
A: Tobin Jack J received 700 CME Group shares at $275.09 per share on 15 September 2026. His resulting holding was 26,109 shares.
Q: How many CME Group shares did Tobin Jack J forfeit?
A: Tobin Jack J forfeited 347 CME Group shares through four transactions between 15 September 2026 and 16 September 2026. The prices ranged from $272.46 to $275.09 per share.
Q: What was Tobin Jack J’s final CME Group share holding?
A: After the forfeiture transactions, Tobin Jack J held 25,762 CME Group shares. The forfeitures represented about 1.3% of his prior share holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.